Autoantibodies against RELL2 were unexpectedly observed in many patients with hypomorphic RAG 1/2 mutations, and these autoantibodies targeting RELL2 may potentially contribute to the inflammation observed in patients with Omenn syndrome [87]. This evidence concerns the gene RELL2 and Omenn syndrome.